Case Series

Diagnosis and Management of Accelerated Phase CML
Diagnosis and Management of Accelerated Phase CML
CME, CPE
Jonathan Webster, MD, and B. Douglas Smith, MD
Release Date: September 11, 2015
Expiration Date: September 11, 2016
Join Managing CML experts B. Douglas Smith, MD, associate professor of oncology, Johns Hopkins University School of Medicine, and Jonathan A. Webster, MD, an oncology fellow at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, in a case-based presentation regarding the diagnosis and treatment planning of a CML patient who is in accelerated phase at the time of diagnosis. Topics covered include the criteria for diagnosis of AP-CML, review of treatment options and treatment selection, monitoring for response to treatment, and navigating subsequent progression with the emergence of a T315I mutation..

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from ARIAD Pharmaceuticals, Inc., Novartis, and Teva Pharmaceuticals.
View Only, CE ExpiredView Only, No Credit
 
Challenging Cases in CML: Treatment Failure in First-line Therapy
Challenging Cases in CML: Treatment Failure in First-line Therapy
CME, CPE
Elias Jabbour, MD
Release Date: March 09, 2015
Expiration Date: March 09, 2016
Dr. Jabbour discusses a case of a patient with CML with resistance to TKI. The patient is a 58-year-old African American male who was diagnosed with chronic myeloid leukemia following a regular checkup. His past medical history was significant for diabetes mellitus and chronic obstructive pulmonary disease.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from ARIAD Pharmaceuticals, Inc., Novartis and Teva Pharmaceuticals.
View Only, CE ExpiredView Only, No Credit